BISCHOFBERGER NORBERT W

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$10.26M
Insider Sells Quantity
52
Insider Sells Sum
$386.16M

Insider Activity of BISCHOFBERGER NORBERT W

According to the SEC Form 4 filings, BISCHOFBERGER NORBERT W, being in a position of

  1. PRESIDENT & CEO at Kronos Bio, Inc.,
    оver the last 12 months, has bought 5351696 shares for $5.32M, and sold 0 shares,
    over all time since 2020-10-14, has bought 5857052 shares for $10.26M, and sold 0 shares.

The largest purchase of all time was on 2020-10-14 and amounted to 191000 shares of Kronos Bio, Inc. for $3.63M.

The largest sale of all time was on 2015-06-15 and amounted to 140000 shares of Gilead Sciences, Inc. for $16.47M.

Biography of BISCHOFBERGER NORBERT W

No biography is available at this moment.

2024-06-28PurchaseKronos Bio, Inc.
KRON
PRESIDENT & CEO
204,670
0.4456%
$1.25$254,9570%
2024-06-27PurchaseKronos Bio, Inc.
KRON
PRESIDENT & CEO
410,848
0.8369%
$1.17$478,8430%
2024-06-12PurchaseKronos Bio, Inc.
KRON
PRESIDENT & CEO
881,913
1.586%
$1.24$1.1M-22.44%
2024-06-11PurchaseKronos Bio, Inc.
KRON
PRESIDENT & CEO
744,308
1.1787%
$1.09$814,571-13.56%
2024-06-10PurchaseKronos Bio, Inc.
KRON
PRESIDENT & CEO
1.38M
2.1146%
$0.88$1.21M+4.66%
2023-11-17PurchaseKronos Bio, Inc.
KRON
President & CEO
97,935
0.167%
$1.08$106,162-1.85%
2023-11-16PurchaseKronos Bio, Inc.
KRON
President & CEO
262,433
0.4271%
$1.00$261,514+0.47%
2023-11-15PurchaseKronos Bio, Inc.
KRON
President & CEO
1.37M
2.1008%
$0.80$1.1M+17.76%
2022-05-17PurchaseKronos Bio, Inc.
KRON
President & CEO
300,000
0.5131%
$3.78$1.13M-36.55%
2021-12-06PurchaseKronos Bio, Inc.
KRON
President & CEO
14,356
0.0258%
$12.09$173,492-60.68%
2020-10-14PurchaseKronos Bio, Inc.
KRON
President & CEO
191,000
0.2434%
$19.00$3.63M-14.59%
2015-12-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
70,000
0.0048%
$102.41$7.17M-17.19%
2015-11-16SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0095%
$102.65$14.37M-16.18%
2015-10-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0094%
$100.05$14.01M-13.21%
2015-09-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0095%
$110.70$15.5M-18.92%
2015-08-17SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0095%
$116.16$16.26M-19.76%
2015-07-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
132,522
0.0091%
$118.20$15.66M-15.96%
2015-07-07SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
7,478
0.0005%
$119.39$892,801-13.51%
2015-06-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0095%
$117.67$16.47M-14.11%
2015-05-15SaleGilead Sciences, Inc.
GILD
EVP, R&D and CSO
140,000
0.0095%
$109.45$15.32M-5.21%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.